Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis

Molecular and Cellular Biology

Volumn 26, Issue 23, 2006, Pages 8683-8696

  Liu, Yuan ^a   Smith, Philip W ^a   Jones, David R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; GENE PRODUCT; HISTONE DEACETYLASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; PROTEIN BRMS1; PROTEIN SUBUNIT; REPRESSOR PROTEIN; SMALL INTERFERING RNA; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BFL 1 A1 GENE; BREAST CANCER; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL VIABILITY; CHROMATIN; CIAP2 GENE; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KNOCKOUT GENE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM; REPRESSOR GENE; SEQUENCE HOMOLOGY; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ACETYLATION; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; ESCHERICHIA COLI; GLUTATHIONE TRANSFERASE; HISTONE DEACETYLASES; HUMANS; NEOPLASM PROTEINS; NF-KAPPA B; PLASMIDS; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 33845207648     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00940-06     Document Type: Article

References (67)

1. Aggarwal, B. B. 2004. Nuclear factor-κB the enemy within. Cancer Cell 6:203-208.
2. Ashburner, B. P., S. D. Westerheide, and A. S. Baldwin, Jr. 2001. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) compressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21:7065-7077.
3. Baeuerle, P. A. 1998. IκB-NF-κB structures: at the interface of inflammation control. Cell 95:729-731.
4. Baldwin, A. S., Jr. 1996. The NF-κB and I κB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
5. Balkwill, F. 2002. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13:135-141.
6. Bitterman, K. J., R. M. Anderson, H. Y. Cohen, M. Latorre-Esteves, and D. A. Sinclair. 2002. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277:45099-45107.
7. Bours, V., E. Dejardin, F. Goujon-Letawe, M. P. Merville, and V. Castronovo. 1994. The NF-κB transcription factor and cancer: high expression of NF-κB- and I κB-related proteins in tumor cell lines. Biochem. Pharmacol. 47:145-149.
8. Chakrabarti, S. K., J. C. James, and R. G. Mirmira. 2002. Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J. Biol. Chem. 277:13286-13293.
9. L. Mol. Cell. Biol. 20:2687-2695.
10. Chen, L., W. Fischle, E. Verdin, and W. C. Greene. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293:1653-1657.
11. Chen, L. F., Y. Mu, and W. C. Greene. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21:6539-6548.
12. Chen, L. F., S. A. Williams, Y. Mu, H. Nakano, J. M. Duerr, L. Buckbinder, and W. C. Greene. 2005. NF-κB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25:7966-7975.
13. Cicek, M., R. Fukuyama, D. R. Welch, N. Sizemore, and G. Casey. 2005. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-κB activity. Cancer Res. 65:3586-3595.
14. Dejardin, E., G. Bonizzi, A. Bellahcene, V. Castronovo, M. P. Merville, and V. Bours. 1995. Highly-expressed p100/p52 (NFKB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11:1835-1841.
15. D'Souza, B. N., L. C. Edelstein, P. M. Pegman, S. M. Smith, S. T. Loughran, A. Clarke, A. Mehl, M. Rowe, C. Gelinas, and D. Walls. 2004. Nuclear factor κB-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. J. Virol. 78:1800-1816.
16. Duffey, D. C., Z. Chen, G. Dong, F. G. Ondrey, J. S. Wolf, K. Brown, U. Siebenlist, and C. Van Waes. 1999. Expression of a dominant-negative mutant inhibitor-κBalpha of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res. 59:3468-3474.
17. Fidler, I. J. 1995. Critical factors in the biology of human cancer metastasis. Am. Surgeon 61:1065-1066.
18. Fischle, W., S. Emiliani, M. J. Hendzel, T. Nagase, N. Nomura, W. Voelter, and E. Verdin. 1999. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J. Biol. Chem. 274:11713-11720.
19. Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
20. Gerritsen, M. E., A. J. Williams, A. S. Neish, S. Moore, Y. Shi, and T. Collins. 1997. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94:2927-2932.
21. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.):S81-S96.
22. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
23. Greten, F. R., L. Eckmann, T. F. Greten, J. M. Park, Z. W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin. 2004. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296.
24. Hassig, C. A., T. C. Fleischer, A. N. Billin, S. L. Schreiber, and D. E. Ayer. 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-347.
25. Hoberg, J. E., A. E. Popko, C. S. Ramsey, and M. W. Mayo. 2006. IκB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol. Cell. Biol. 26:457-471.
26. Hoberg, J. E., F. Yeung, and M. W. Mayo. 2004. SMRT derepression by the IκB kinase alpha: a prerequisite to NF-κB transcription and survival. Mol. Cell 16:245-255.
27. Hong, S. Y., W. H. Yoon, J. H. Park, S. G. Kang, J. H. Ahn, and T. H. Lee. 2000. Involvement of two NF-κB binding elements in tumor necrosis factor alpha-, CD40-, and Epstein-Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J. Biol. Chem. 275:18022-18028.
28. Jemal, A., R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, and M. J. Thun. 2006. Cancerstatistics, 2006. CA Cancer J. Clinicians 56:106-130.
29. Jepsen, K., and M. G. Rosenfeld. 2002. Biological roles and mechanistic actions of co-repressor complexes. J. Cell Sci. 115:689-698.
30. Jones, D. R., R. M. Broad, L. D. Comeau, S. J. Parsons, and M. W. Mayo. 2002. Inhibition of nuclear factor κB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation. J. Thorac. Cardiovasc. Surg. 123:310-317.
31. Jones, D. R., R. M. Broad, L. V. Madrid, A. S. Baldwin, Jr., and M. W. Mayo. 2000. Inhibition of NF-κB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis. Ann. Thorac. Surg. 70:930-937.
32. Karin, M., and F. R. Greten. 2005. NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5:749-759.
33. Kiernan, R., V. Bres, R. W. Ng, M. P. Coudart, S. El Messaoudi, C. Sardet, D. Y. Jin, S. Emiliani, and M. Benkirane. 2003. Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278:2758-2766.
34. Kuo, M. H., and C. D. Allis. 1999. In vivo cross-linking and immunoprecipitation for studying dynamic protein-DNA associations in a chromatin environment. Methods 19:425-433.
35. Laherty, C. D., W. M. Yang, J. M. Sun, J. R. Davie, E. Seto, and R. N. Eisenman. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-356.
36. Lee, C. W., W. N. Lin, C. C. Lin, S. F. Luo, J. S. Wang, J. Pouyssegur, and C. M. Yang. 2006. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-κB, p300. and histone acetylation. J. Cell Physiol. 207:174-186.
37. Lee, D. K., J. E. Kang, H. J. Park, M. H. Kim, T. H. Yim, J. M. Kim, M. K. Heo, K. Y. Kim, H. J. Kwon, and M. W. Hur. 2005. FBI-1 enhances transcription of the nuclear factor-κB (NF-κB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-κB. J. Biol. Chem. 280:27783-27791.
38. Liu, Y., C. E. Denlinger, B. K. Rundall, P. W. Smith, and D. R. Jones. 21 August 2006, posting date. SAHA induces Akt-mediated phosphorylation of p300 which promotes acetylation and transcriptional activation of RelA/p65. J. Biol. Chem. [Online.] doi: 10.1074/jbc.M604478200.
39. Locke, D. 1998. Gap junctions in normal and neoplastic mammary gland. J. Pathol. 186:343-349.
40. Marks, P., R. A. Rifkind, V. M. Richon, R. Breslow, T. Miller, and W. K. Kelly. 2001. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1:194-202.
41. Mayo, M. W., C. E. Denlinger, R. M. Broad, F. Yeung, E. T. Reilly, Y. Shi, and D. R. Jones. 2003. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-κB through the Akt pathway. J. Biol. Chem. 278:18980-18989.
42. Meehan, W. J., R. S. Samant, J. E. Hopper, M. J. Carrozza, L. A. Shevde, J. L. Workman, K. A. Eckert, M. F. Verderame, and D. R. Welch. 2004. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma- binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J. Biol. Chem. 279:1562-1569.
43. Meehan, W. J., and D. R. Welch. 2003. Breast cancer metastasis suppressor 1: update. Clin. Exp. Metastasis 20:45-50.
44. Mountain, C. F. 1997. Revisions in the international system for staging lung cancer. Chest 111:1710-1717.
45. Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380.
46. Nakshatri, H., P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet, Jr., and G. W. Sledge, Jr. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629-3639.
47. Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523-527.
48. Pikarsky, E., R. M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah. 2004. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461-466.
49. Rodeck, U., M. Jost, J. DuHadaway, C. Kari, P. J. Jensen, B. Risse, and D. L. Ewert. 1997. Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 94:5067-5072.
50. Roth, S. Y., J. M. Denu, and C. D. Allis. 2001. Histone acetyltransferases. Annu. Rev. Biochem. 70:81-120.
51. Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353-30356.
52. Samant, R. S., M. J. Seraj, M. M. Saunders, T. S. Sakamaki, L. A. Shevde, J. F. Harms, T. O. Leonard, S. F. Goldberg, L. Budgeon, W. J. Meehan, C. R. Winter, N. D. Christensen, M. F. Verderame, H. J. Donahue, and D. R. Welch. 2000. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp. Metastasis 18:683-693.
53. Saunders, M. M., M. J. Seraj, Z. Li, Z. Zhou, C. R. Winter, D. R. Welch, and H. J. Donahue. 2001. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res. 61:1765-1767.
54. Seraj, M. J., M. A. Harding, J. J. Gildea, D. R. Welch, and D. Theodorescu. 2000. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin. Exp. Metastasis 18:519-525.
55. Seraj, M. J., R. S. Samant, M. F. Verderame, and D. R. Welch. 2000. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res. 60:2764-2769.
56. Sheppard, K. A., D. W. Rose, Z. K. Haque, R. Kurokawa, E. McInerney, S. Westin, D. Thanos, M. G. Rosenfeld, C. K. Glass, and T. Collins. 1999. Transcriptional activation by NF-κB requires multiple coactivators. Mol. Cell. Biol. 19:6367-6378.
57. Shevde, L. A., R. S. Samant, S. F. Goldberg, T. Sikaneta, A. Alessandrini, H. J. Donahue, D. T. Mauger, and D. R. Welch. 2002. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp. Cell Res. 273:229-239.
58. Sovak, M. A., R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A. M. Traish, and G. E. Sonenshein. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Investig. 100:2952-2960.
59. Tripathi, A. K., D. J. Sullivan, and M. F. Stins. 2006. Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-κB. Infect. Immun. 74:3262-3270.
60. Wang, C. Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin, Jr. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and C-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
61. Wang, W., J. L. Abbruzzese, D. B. Evans, L. Larry, K. R. Cleary, and P. J. Chiao. 1999. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res. 5:119-127.
62. Warn-Cramer, B. J., P. D. Lampe, W. E. Kurata, M. Y. Kanemitsu, L. W. Loo, W. Eckhart, and A. F. Lau. 1996. Characterization of the mitogen-activated protein kinase phosphorylation sites on the connexin 43 gap junction protein. J. Biol. Chem. 271:3779-3786.
63. Yan, W., and R. Shao. 2006. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J. Biol. Chem. 281:19700-19708.
64. Yeung, F., J. E. Hoberg, C. S. Ramsey, M. D. Keller, D. R. Jones, R. A. Frye, and M. W. Mayo. 2004. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23:2369-2380.
65. Zhong, H., M. J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9:625-636.
66. Zhu, Z., O. Sanchez-Sweatman, X. Huang, R. Wiltrout, R. Khokha, Q. Zhao, and E. Gorelik. 2001. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res. 61:1707-1716.
67. Zong, W. X., L. C. Edelstein, C. Chen, J. Bash, and C. Gelinas. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13:382-387.